Effects of opicinumab on patient reported outcomes in participants with relapsing multiple sclerosis: A post-hoc analysis of the phase II Synergy study

Document Type

Presentation

Publication Date

2018

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences

This document is currently not available here.

Share

COinS